Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 5/20 | 0.71 |
| ▸ | GLP1R | P43220 | 8/20 | 0.65 |
| ▸ | EPHX2 | P34913 | 6/20 | 0.61 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16259359 | 1.00 | NOD1 (0.71) | NOD1GLP1REPHX2SLC6A5 | |
| SCHEMBL20162097 | 1.00 | NOD1 (0.71) | NOD1GLP1REPHX2SLC6A5 | |
| SCHEMBL16259357 | 1.00 | NOD1 (0.71) | NOD1GLP1REPHX2SLC6A5 | |
| SCHEMBL16259355 | 1.00 | NOD1 (0.71) | NOD1GLP1REPHX2SLC6A5 | |
| SCHEMBL13855525 | 0.96 | NOD1 (0.76) | NOD1GLP1REPHX2SLC6A5 | |
| SCHEMBL14937349 | 0.96 | NOD1 (0.76) | NOD1GLP1REPHX2SLC6A5 | |
| SCHEMBL14937344 | 0.96 | NOD1 (0.76) | NOD1GLP1REPHX2SLC6A5 | |
| SCHEMBL7041680 | 0.96 | NOD1 (0.76) | NOD1GLP1REPHX2SLC6A5 | |
| SCHEMBL14937066 | 0.96 | NOD1 (0.76) | NOD1GLP1REPHX2SLC6A5 | |
| SCHEMBL542980 | 0.96 | NOD1 (0.76) | NOD1GLP1REPHX2SLC6A5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3323868-B1 | GEL COMPOSITION CONTAINING ACYL BASIC AMINO ACID DERIVATIVE | AJINOMOTO KK (JP) | 2020-05-13 | — | — | EP | claimed |
| EP-3323868-A1 | GEL COMPOSITION CONTAINING ACYL BASIC AMINO ACID DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2018-05-23 | — | — | EP | claimed |
| EP-3323868-B1 | GEL COMPOSITION CONTAINING ACYL BASIC AMINO ACID DERIVATIVE | AJINOMOTO KK (JP) | 2020-05-13 | — | — | EP | disclosed |
| EP-3323868-A1 | GEL COMPOSITION CONTAINING ACYL BASIC AMINO ACID DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2018-05-23 | — | — | EP | disclosed |
| US-9198846-B2 | Basic amino acid derivative | AJINOMOTO CO., INC. (JP) | 2015-12-01 | — | — | US | disclosed |
| US-20140350128-A1 | BASIC AMINO ACID DERIVATIVE | AJINOMOTO CO., INC. (JP) | 2014-11-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140350128-A1 | BASIC AMINO ACID DERIVATIVE | BCAT2, BCAT1, SLC7A1 | NOD1 3568/4885GLP1R 1896/4885EPHX2 3313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.